Day: September 20, 2022

Sep 20
Microsoft boosts quarterly dividend by 9.7%

Shares of Microsoft Corp. MSFT, -1.32% fell 0.7% in premarket trading Tuesday, after the software behemoth said it raised its quarterly dividend by 9.7%, to 68 cents a share from 62 cents a share. The new dividend will be payable Dec. 8 to shareholders of record on Nov. 17. Based on Monday’s stock closing price […]

Sep 20
FTC asks Amazon and iRobot for additional information and documentary materials relating to their deal

The Federal Trade Commission has requested additional information and documentary materials from Amazon.com Inc. AMZN, -1.52% and Roomba parent iRobot Corp. IRBT, -0.43% relating to their planned merger, according to a regulatory filing on Tuesday. The companies expect to promptly respond to the request, which will extend the waiting period imposed by the Hart-Scott-Rodino Antitrust […]

Sep 20
Truist upgrades Norwegian Cruise Line to buy from hold amid better industry bookings

Shares of Norwegian Cruise Line Holdings Ltd. NCLH, +0.26% rose 3% in premarket trades Tuesday, as Truist Securities analyst C. Patrick Scholes upgraded the stock to buy from hold and hiked its price target by $1 to $19 a share. With booking volumes and pricing for luxury lines improving, Norwegian Cruise Line is positioned to […]

Sep 20
Apogee’s record profit and sales beats expectations, amid strength in architectural framing and services

Apogee Enterprises Inc. APOG, +3.96% reported Tuesday record fiscal second-quarter profit and sales that beat expectations, citing strength in its architectural framing systems and services businesses. For the quarter to Aug. 27, the provider of architectural products and services for enclosing buildings swung to net income of $37.4 million, or $1.68 a share, from a […]

Sep 20
Alameda Research ‘happy to return’ $200M loan to Voyager Digital

The trading company will pay back the debt, which has fallen almost twice in dollar estimate, by the end of September. 1461 Total views 31 Total shares Quantitative trading company Alameda Research will return an estimate of $200 million to Voyager Digital, which is proceeding through bankruptcy. Alameda borrowed the funds in cryptocurrencies in September 2021. […]

Sep 20
Nordstrom adopts 1-year ‘poison pill’ to block any entity from gaining control

Shares of Nordstrom Inc. JWN, +3.92% slipped 0.3% in premarket trading Tuesday, after the higher-end department store chain said it adopted a shareholder rights plan, also known as a “poison pill,” that is effective immediately and lasts for one year. Nordstrom said the rights plan, which becomes exercisable if a person or entity acquires 10% […]

Sep 20
Morgan Stanley agrees to pay fine for failing to protect personal identifying info

Morgan Stanley MS, +1.48% has agreed to pay a $35 million fine for failing to protect personal identifying information on about 15 million customers, the Securities and Exchange Commission said Tuesday. The investment bank hired a moving company that then sold to a third party “thousands of Morgan Stanley devices including servers and hard drives, […]

Sep 20
BorgWarner to buy EV charging business of China-based Hubei SSE

BorgWarner Inc. BWA, +2.06% announced Tuesday and equity transfer agreement to buy the electric vehicle (EV) charging business of China-based Hubei Surpass Sun Electric (SSE) in a deal valued at up to RMB410 million ($58.5 million). The deal includes RMB267 million to be delivered around the closing, which is expected to occur in the first […]

Sep 20
Amazon in agreement with Infinium to add low carbon electrofuels to trucking fleet

Amazon.com Inc. AMZN, +0.91% said Tuesday it has signed an agreement with Infinium to add low carbon electrofuels to its trucking fleet starting in 2023. The company Infinium will provide enough electrofuels — s fossil-based fuel alternative created with carbon waste and renewable power — to power about 5 million miles of travel a year. […]

Sep 20
Merck launches new Phase 3 trial of once-daily HIV treatment, to discontinue trial of once-monthly dose

Merck MRK, -1.23% said Tuesday it is launching a new Phase 3 trial of once-daily islatravir for the treatment of people with HIV-1 infection. “These new Phase 3 studies will evaluate a once-daily oral combination of doravirine 100 mg and a lower dose of islatravir (DOR/ISL),” the company said in a statement. Certain participants currently […]